Rev1 Participates in Prevedere’s $10 Million Series B Round
Rev1 participated in Prevedere’s $10 million Series B round to help the company accelerate enterprise market adoption of its cloud-based predictive analytics solution.
Prevedere’s $10 Million Series B Round
This news signals the first investment from Rev1 Fund I, the new groundbreaking corporate-backed fund supported by Nationwide, The Ohio State University, Cardinal Health, and other top companies and organizations, including The Ohio Third Frontier.
One of Rev1’s earlier seed funds was the first investor in Prevedere five years ago and we’ve supported the company’s growth with capital and strategic services since its formation.
Why is this big news for the Columbus region?
Prevedere is a model for a successful Central Ohio startup. As a result of its customer-centric approach, Prevedere has attracted attention and capital from West Coast investors, while maintaining its strong presence in Ohio.
This is an exciting day for our region because it proves that – by working together – we can support early-stage companies as they grow up right here in our backyard.